article thumbnail

Nektar pads wallet with $90M manufacturing plant sale to Ampersand

Fierce Pharma

The deal is expected to extend Nektar's cash runway into 2026 and help the company hone its development of novel immunology drugs.

article thumbnail

FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic

Fierce Pharma

FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic fkansteiner Wed, 02/14/2024 - 05:10

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bain Capital eyes potential €1B sale of Dutch antibiotics manufacturer Centrient: report

Fierce Pharma

As bankers predict a rise in private equity exits this year, one of 2024’s M&A moves could come from the drug manufacturing realm. billion), Bloomberg reported Wednesday, citing people close to the talks.

article thumbnail

Sales Skills You Will Need As A Medical Sales Rep With Andy Olen

Evolve Your Success

From Ted Talks to the medical sales podcast! In this episode, he discusses the essential sales skills required for success as a medical sales representative. Discover Andy’s expertise as he guides high-performing individuals, executive sales leaders, and professional athletes through his coaching and training organization.

article thumbnail

Contract manufacturing giant WuXi's stock plummets as it warns of $400M revenue miss

Fierce Pharma

A challenging year for the biotech industry has taken a heavy toll on Chinese manufacturer WuXi Biologics, sending the company’s stock plummeting nearly 24% Monday. WuXi Biologics expects to miss its original sales target for the year by around $400 million, thanks to reductions across its development and manufacturing services.

article thumbnail

Eli Lilly 'aggressively planning' manufacturing expansions, CEO says, as Mounjaro soars

Fierce Pharma

But strong demand continues to push sales of the GLP-1/GIP agonist to new highs ahead of an FDA decision on weight loss. | As strong demand continues to push Mounjaro sales to new highs, Eli Lilly CEO David Ricks said the company is "not done with" manufacturing expansions.

article thumbnail

Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics

Fierce Pharma

Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics aliu Thu, 03/30/2023 - 16:18